Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis
Open Access
- 1 December 1993
- journal article
- review article
- Published by Elsevier in Bone and Mineral
- Vol. 23 (3) , 223-232
- https://doi.org/10.1016/s0169-6009(08)80099-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effects of ipriflavone and its metabolites on a clonal osteoblastic cell lineJournal of Bone and Mineral Research, 1991
- Effect of catechins and citrus flavonoids on invasionin vitroClinical & Experimental Metastasis, 1991
- Suppressive effect of ipriflavone on bone depletion in the experimental diabetic rat : Dose response of ipriflavoneLife Sciences, 1988
- Modification of arachidonic metabolism by flavonoidsJournal of Ethnopharmacology, 1987
- Calcitonin secreting property of ipriflavone in the presence of estrogenLife Sciences, 1986
- The effect of ipriflavone (TC-80) on bone resorption in tissue cultureJournal of Bone and Mineral Research, 1986
- Effect of ipriflavone on glucocorticoid-induced osteoporosis in ratsLife Sciences, 1986
- Effect of ipriflavone on the response of uterus and thyroid to estrogenLife Sciences, 1986
- Effect of ipriflavone on bone changes induced by calcium restricted, vitamin D deficient diet in rats.Endocrinologia Japonica, 1986
- Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesteraseCellular and Molecular Life Sciences, 1978